Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 6/2012

01-12-2012 | Research Article

Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians

Authors: Shan Zhong, Jia-He Yang, Kai Liu, B. H. Jiao, Zhi-Jie Chang

Published in: Tumor Biology | Issue 6/2012

Login to get access

Abstract

A great number of studies regarding the association between MTHFR C677T polymorphism and risk of colorectal cancer (CRC) in East Asians were published, but the results were inconsistent. Thus, a meta-analysis was performed to investigate the association. PubMed, Embase, and CBM databases were searched for eligible publications. Pooled odds ratios (ORs) with 95 % confidence intervals (95 % CIs) were calculated using random or fixed effect models. Finally, 24 case–control studies with a total of 7,230 CRC cases and 9,285 controls were included. Meta-analyses of a total of 24 studies showed there was a statistically significant association between MTHFR C677T polymorphism and decreased CRC risk in East Asians under four genetic models (T versus C, OR = 0.92, 95 % CI 0.85–0.99; TT versus CC, OR = 0.80, 95 % CI 0.69–0.94; TT versus CT/CC, OR = 0.82, 95 % CI 0.71–0.95; TT/CT versus CC, OR = 0.92, 95 % CI 0.86–0.98). The cumulative meta-analyses for the allele contrast (T versus C), homozygote (TT versus CC), dominant (TT/CT versus CC), and recessive (TT versus CT/CC) models all showed a trend of more obvious association as information accumulated by year. Subgroup analyses by country further identified this association in Korea and Japan. This meta-analysis suggests that MTHFR C677T polymorphism is associated with decreased risk of colorectal cancer in East Asians, and MTHFR 677T variant has a protective effect on colorectal cancer.
Appendix
Available only for authorised users
Literature
1.
2.
Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–6.PubMedCrossRef
3.
Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010;25:1113–21.PubMedCrossRef
4.
Katanoda K, Ajiki W, Matsuda T, Nishino Y, Shibata A, Fujita M, et al. Trend analysis of cancer incidence in Japan using data from selected population-based cancer registries. Cancer Sci. 2012;103:360–8.PubMedCrossRef
5.
Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449–60.PubMedCrossRef
6.
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. Colorectal cancer. Lancet. 2010;375:1030–47.PubMedCrossRef
7.
Bailey LB, Gregory III JF. Folate metabolism and requirements. J Nutr. 1999;129:779–82.PubMed
8.
Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7:195–200.PubMedCrossRef
9.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–3.PubMedCrossRef
10.
Yin G, Kono S, Toyomura K, Hagiwara T, Nagano J, Mizoue T, et al. Methylenetetrahydrofolate reductase c677t and a1298c polymorphisms and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci. 2004;95:908–13.PubMedCrossRef
11.
Kim DH, Ahn YO, Lee BH, Tsuji E, Kiyohara C, Kono S. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett. 2004;216:199–205.PubMedCrossRef
12.
Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, et al. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev. 2005;29:146–54.PubMedCrossRef
13.
Cui LH, Shin MH, Kweon SS, Kim HN, Song HR, Piao JM, et al. Methylenetetrahydrofolate reductase c677t polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer. 2010;10:236.PubMedCrossRef
14.
Petitti DB. Meta-analysis, decision analysis, and cost effectiveness analysis: methods for quantitative synthesis in medicine. 2nd ed. New York: Oxford University Press; 2000.
15.
Huang Y, Han S, Li Y, Mao Y, Xie Y. Different roles of mthfr c677t and a1298c polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet. 2007;52:73–85.PubMedCrossRef
16.
Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, et al. Meta- and pooled analyses of the methylenetetrahydrofolate reductase (mthfr) c677t polymorphism and colorectal cancer: a huge-gsec review. Am J Epidemiol. 2009;170:1207–21.PubMedCrossRef
17.
Hubner RA, Houlston RS. Mthfr c677t and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer. 2007;120:1027–35.PubMedCrossRef
18.
Kim J, Cho YA, Kim DH, Lee BH, Hwang DY, Jeong J, et al. Dietary intake of folate and alcohol, mthfr c677t polymorphism, and colorectal cancer risk in Korea. Am J Clin Nutr. 2012;95:405–12.PubMedCrossRef
19.
Kang BS, Ahn DH, Kim NK, Kim JW. Relationship between metabolic syndrome and mthfr polymorphism in colorectal cancer. J Korean Soc Coloproctol. 2011;27:78–82.PubMedCrossRef
20.
Lee JE, Wei EK, Fuchs CS, Hunter DJ, Lee IM, Selhub J, Stampfer MJ, Willett WC, Ma J, Giovannucci E: Plasma folate, methylenetetrahydrofolate reductase (mthfr), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control 2012
21.
Attia J, Thakkinstian A, D’Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297–303.PubMedCrossRef
22.
Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy-weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13:840–8.PubMedCrossRef
23.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
24.
25.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
26.
Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRef
27.
Galbraith R. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7:889–94.PubMedCrossRef
28.
Thompson SG, Higgins J. How should meta–regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559–73.PubMedCrossRef
29.
Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248–54.PubMedCrossRef
30.
Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–45.PubMedCrossRef
31.
Muellerleile P, Mullen B. Sufficiency and stability of evidence for public health interventions using cumulative meta-analysis. Am J Public Health. 2006;96:515–22.PubMedCrossRef
32.
Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8:15–7.
33.
Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469.PubMedCrossRef
34.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef
35.
Miao XP, Yang S, Tan W, Zhang XM, Ye YJ, Lin DX, et al. association between genetic variations in methylenetetrahydrofolate reductase and risk of colorectal cancer in a chinese population. Zhonghua Yu Fang Yi Xue Za Zhi. 2005;39:409–11.PubMed
36.
Jin XX, Zhu ZZ, Wang AZ, Jia HR. Association of methylenetetrahydrofoiate reductase c677t polymorphism with genetic susceptibility to colorectal cancer. Shijie Huaren Xiao Hua Za Zhi. 2007;15:2754–7.
37.
Zhu Q, Jin Z, Yuan Y, Lu Q, Ge D, Zong M. Impact of mthfr gene c677t polymorphism on bcl-2 gene methylation and protein expression in colorectal cancer. Scand J Gastroenterol. 2011;46:436–45.PubMedCrossRef
38.
Kim JW, Park HM, Choi YK, Chong SY, Oh D, Kim NK. Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients. Oncol Rep. 2011;25:167–72.PubMed
39.
Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Natsukawa S, et al. Folate, vitamin b6, vitamin b12, and vitamin b2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer. 2005;53:42–50.PubMedCrossRef
40.
Zhang YL, Yuan XY, Zhang C, Yang Y, Pan YM, Zhou ZY, et al. Relationship between polymorphisms of thymidylate synthase and methylenetetrahydrofolate reductase and susceptibility in Liaoning Benxi colorectal cancer pafients. Linchuang Zhong Liu Xue Za Zhi. 2008;13:769–74.
41.
Promthet SS, Pientong C, Ekalaksananan T, Wiangnon S, Poomphakwaen K, Songserm N, Chopjitt P, Moore MA, Tokudome S: Risk factors for colon cancer in northeastern thailand: interaction of mthfr codon 677 and 1298 genotypes with environmental factors. Journal of Epidemiology 2010:1006080172.
42.
Chang SC, Lin PC, Lin JK, Yang SH, Wang HS, Li AF. Role of mthfr polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis. 2007;22:483–9.PubMedCrossRef
43.
Yang XX, Li FX, Yi JP, Li X, Sun JZ, Hu NY. Association of mthfr c677t polymorphism and susceptibility of lung cancer, gastric cancer and colorectal cancer risk. Guangdong Yi Xue. 2010;31:2375–8.
44.
Park KS, Mok JW, Kim JC. The 677c>t mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test. 1999;3:233–6.PubMedCrossRef
45.
Zhu F, Wang YM, Zhang QM. A case-control study of plasma homocysteine, serum folate, the polymorphism of methylenetetrahydrofolate reductase in colorectai cancer. Dongnan Da Xue Xue Bao. 2010;29:88–92.
46.
Matsuo K, Ito H, Wakai K, Hirose K, Saito T, Suzuki T, et al. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis. 2005;26:2164–71.PubMedCrossRef
47.
Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, et al. Methionine synthase reductase gene a66g polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev. 2002;3:353–9.PubMed
48.
Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev. 2008;9:203–8.PubMed
49.
Huang P, Zhou ZY, Ma HT, Liu JY, Zhou YH, Cao J, et al. Mthfr polymorphisms and colorectal cancer susceptibility in chongging people. Acta Academiae Medicinae Militaris Tertiae. 2003;25:1710–5.
50.
Jiang QT, Chen K, Ma XY, Miao XP, Yao KY, Yu WP, et al. a case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:612–6.PubMed
51.
Li H, Xu WL, Shen HL, Chen QY, Hui LL, Long LL, Zhu XL: Methylenetetrahydrofolate reductase genotypes and haplotypes associated with susceptibility to colorectal cancer in an eastern Chinese Han population. Genet Mol Res 2011;10
52.
Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007;335:914–6.PubMedCrossRef
53.
Hao L, Tian YH, Tan M, Tang Y, Li Z. Variation of plasma folate levels in adults with ages 35-64 years between some areas in China. Acta Nutrimenta Sinica. 2002;24:352–6.
54.
Kim DH. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer. Mutat Res. 2007;622:14–8.PubMedCrossRef
55.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. Grade guidelines: 1. Introduction-grade evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94.PubMedCrossRef
56.
Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, et al. Mthfr c677t polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res Treat. 2010;123:549–55.PubMedCrossRef
57.
Jin F, Qu LS, Shen XZ. Association between the methylenetetrahydrofolate reductase c677t polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol. 2009;4:39.PubMedCrossRef
58.
Dong X, Wu J, Liang P, Li J, Yuan L, Liu X. Methylenetetrahydrofolate reductase c677t and a1298c polymorphisms and gastric cancer: a meta-analysis. Arch Med Res. 2010;41:125–33.PubMedCrossRef
59.
Zhang Y, Chen GQ, Ji Y, Huang B, Shen WS, Deng LC, et al. Quantitative assessment of the effect of mthfr polymorphisms on the risk of lung carcinoma. Mol Biol Rep. 2012;39:6203–11.PubMedCrossRef
Metadata
Title
Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians
Authors
Shan Zhong
Jia-He Yang
Kai Liu
B. H. Jiao
Zhi-Jie Chang
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2012
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-012-0463-7

Other articles of this Issue 6/2012

Tumor Biology 6/2012 Go to the issue

Research Article

PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group

Research Article

Anti-apoptotic effect of claudin-1 on TNF-α-induced apoptosis in human breast cancer MCF-7 cells

Research Article

Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer

Research Article

Differential gene expression of Wnt signaling pathway in benign, premalignant, and malignant human breast epithelial cells

Research Article

Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma

Research Article

Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits